Befejeződött1. fázis
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants with Early Idiopathic Parkinson’s Disease
Key facts
- Where
- Amsterdam, Nijmegen és Zwolle, HollandiaSee the 3 sites
- Phase
- 1. fázis
Where in Hollandia
- Brain Research Center Amsterdam B.V.Amsterdam, HollandiaNo longer taking part
- Stichting Radboud University Medical CenterNijmegen, HollandiaNo longer taking part
- Brain Research Center Zwolle B.V.Zwolle, HollandiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F. Hoffmann-La Roche AG
- Trial code
- EU 2023-504412-14-00
- Record updated
- 2023. december 20.